Feasibility Evaluation of a Monitored Self-guided Cognitive Behavioural Therapy Digital Format

December 11, 2020 updated by: Martin Kraepelien, Karolinska Institutet

Feasibility Evaluation of a Monitored Self-guided Digital Cognitive Behavioural Therapy Format: an Uncontrolled Trial of a Problem Solving Intervention for Depression and Anxiety

The purpose of the study is to evaluate the feasibility of a new monitored self-guided digital cognitive behavioural therapy format through one of the key components of an intervention for depression and anxiety (Problem Solving) and to answer the question: Do patients with significant levels of depression and/or anxiety symptoms consider the monitored self-guided digital format usable and credible? An uncontrolled trial will explore participant's usability and treatment credibility ratings.

Study Overview

Status

Completed

Detailed Description

Objective. The purpose of the study is to evaluate the feasibility of a new monitored self-guided digital cognitive behavioural therapy format through one of the key components of an intervention for depression and anxiety (Problem Solving) and to answer the question: Do patients with significant levels of depression and/or anxiety symptoms consider the monitored self-guided digital format usable and credible?

Background. Problem Solving is a behavioral modification intervention focusing on the training of adaptive problem-solving skills in order to cope more effectively with everyday stressful events. It is one of the most well-examined therapeutic interventions for depression, with reliable support regarding symptom improvement in depression traditionally delivered with therapist-guidance when administered via the Internet. Since a new monitored self-guided digital intervention for depression and anxiety has been developed, including the key component Problem Solving, it is of importance to assess both the usability and treatment-credibility of this format to evaluate if it is feasible.

Methodology. Based on similar feasibility studies including around ten participants, a number of 16-30 participants will be included in this study to compensate for potential drop-outs. Participants will be recruited via a psychiatric clinic belonging to Stockholm County Council in Stockholm, Sweden, and will be patients in queue for treatment for depression and/or anxiety in a psychiatric setting. Inclusion criteria will be significant depression and/or anxiety symptoms. The participants included in the study will access the key component Problem Solving during four weeks while being on waitlist for regular treatment. They will be introduced to the intervention as a self-explanatory tool with possible beneficial effects on depression symptoms. Self-assessments will be carried out during the intervention. The scores on these scales will be compared to available published data from these scales from evaluations of therapist-guided Internet-based interventions if available, and otherwise data from these scales from studies on other digital interventions for mental health. The participants will also answer questions concerning their experience of the format.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Centrum för Psykiatriforskning

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Significant depression and/or anxiety symptoms measured with Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder (GAD-7) (i.e. a PHQ-9 and/or GAD-7 score of ≥5).

Exclusion Criteria:

  1. insufficient Swedish knowledge
  2. minor (i.e. age <18 years)
  3. high suicide risk (i.e. a score ≥4 on the ninth item on the Montgomery Åsberg Depression Scale, MADRS-S)
  4. lack of access to a device with Internet connection (e.g. computer, mobile, tablet)
  5. lack of access to a phone on which calls and SMS can be received
  6. psychiatric or somatic problems that must be prioritized before or become an excessive obstacle to the intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Monitored self-guided problem solving intervention
Problem Solving is a behavioral modification intervention focusing on the training of adaptive problem-solving skills in order to cope more effectively with everyday stressful events.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
System Usability Scale
Time Frame: immediately after the intervention
Self-rated assessment of usability, higher score is better
immediately after the intervention
Treatment Credibility Scale
Time Frame: immediately after the intervention
Self-rated assessment of treatment credibility, higher score is better
immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Negative Effects Questionnaire
Time Frame: immediately after the intervention
Self-rated assessment of negative treatment effects, lower score is better
immediately after the intervention
Negative Effects Questionnaire
Time Frame: During the intervention: 2 weeks from baseline
Self-rated assessment of negative treatment effects, lower score is better
During the intervention: 2 weeks from baseline
Patient Health Questionnaire - 9
Time Frame: Change from baseline immediately after the intervention
Self-rated depressive symptoms, lower score is better
Change from baseline immediately after the intervention
Generalized Anxiety Disorder - 7
Time Frame: Change from baseline immediately after the intervention
Self-rated anxiety symptoms, lower score is better
Change from baseline immediately after the intervention
System Usability Scale
Time Frame: During the intervention: 2 weeks from baseline
Self-rated assessment of usability, higher score is better
During the intervention: 2 weeks from baseline
Treatment Credibility Scale
Time Frame: During the intervention: 2 weeks from baseline
Self-rated assessment of treatment credibility, higher score is better
During the intervention: 2 weeks from baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of treatment format
Time Frame: During the intervention: 2 weeks from baseline
Written quantitative and qualitative questions concerning the treatment format
During the intervention: 2 weeks from baseline
Evaluation of treatment format
Time Frame: immediately after the intervention
Written quantitative and qualitative questions concerning the treatment format
immediately after the intervention
Interview concerning treatment format
Time Frame: immediately after the intervention
Phone interview with qualitative questions concerning the treatment format
immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 24, 2020

Primary Completion (Actual)

December 11, 2020

Study Completion (Actual)

December 11, 2020

Study Registration Dates

First Submitted

February 11, 2020

First Submitted That Met QC Criteria

February 19, 2020

First Posted (Actual)

February 20, 2020

Study Record Updates

Last Update Posted (Actual)

December 14, 2020

Last Update Submitted That Met QC Criteria

December 11, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Monitored self-guided problem solving

3
Subscribe